Back to search

Article

Cheung's Regimen Series: Ultra-Low-Dose Paroxetine as CYP2D6 Inhibitor Enables Safe OTC Glutamatergic Augmentation in a Depressive Patient on Lisdexamfetamine

2025-12-01

Abstract excerpt

A 35-year-old office worker came to our clinic after years of unrelieved depression, mounting anxiety, and lifelong distraction. Several antidepressants had failed, and a recent hospitalisation for suicidal thoughts underscored the urgency of her situation. Morning lisdexamfetamine 20 mg sharpened her focus but left mood and worry largely untouched. Because she had not responded to serotonergic strategies, an OTC...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
330ef405-9e7d-507f-b42a-f662ee609822
DOI
10.20944/preprints202512.0057.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cheung's Regimen Series: Ultra-Low-Dose Paroxetine as CYP2D6 Inhibitor Enables Safe OTC Glutamatergic Augmentation in a Depressive Patient on LisdexamfetamineDOI 10.20944/preprints202512.0057.v1
Select a neighboring publication to make it the new centre.